540937 — Medico Remedies Income Statement
0.000.00%
- IN₹3.38bn
- IN₹3.45bn
- IN₹1.45bn
- 45
- 19
- 13
- 11
Annual income statement for Medico Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 886 | 1,224 | 1,210 | 1,404 | 1,449 |
Cost of Revenue | |||||
Gross Profit | 215 | 302 | 337 | 356 | 350 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 875 | 1,188 | 1,159 | 1,335 | 1,349 |
Operating Profit | 11.8 | 35.8 | 51.3 | 69 | 100 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.2 | 36.9 | 65.5 | 101 | 113 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.3 | 25.9 | 48.9 | 72.4 | 82.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 16.3 | 25.9 | 48.9 | 72.4 | 82.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16.3 | 25.9 | 48.9 | 72.4 | 82.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.196 | 1.25 | 0.589 | 0.873 | 0.999 |